# Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis

> **NCT04691232** · PHASE1 · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 11 (actual)

## Conditions studied

- Ulcerative Colitis
- Autoimmune Diseases

## Interventions

- **BIOLOGICAL:** Regulatory T cells

## Key facts

- **NCT ID:** NCT04691232
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-22
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-05-22
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04691232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04691232, "Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04691232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*